Aclaris Therapeutics, Inc. (ACRS)

$1.17 -0.85% $-0.01 Healthcare

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of laboratory services. The company also develops Zunsemetinib, an MK2 inhibitor for the treatment of moderate to severe rheumatoid and Psoriatic arthritis, and Hidradenitis suppurativa; and ATI-1777, a soft JAK 1/3 inhibitor for the treatment of moderate to severe atopic dermatitis. In addition, it develops ATI-2138, an ITK/TXK/JAK3 inhibitor as a potential treatment for T cell-mediated autoimmune diseases; Gut-Biased Program for inflammatory bowel disease; and ATI-2231, an MK2 inhibitor treatment for pancreatic and metastatic breast cancer. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

$83.47M

Dr. Douglas J. Manion Frcp(C), M.D.

72.00

Wayne, PA

Oct 07, 2015

-1.43

$-0.82

1.46

7.50

-183.28%

-1.43

-0.04

0.63

2.63

7.50

-36.43%

-39.83%

Similar stocks (8)

IQVIA Holdings Inc.

IQV

$243.07 -2.04%
Uptrend

Medpace Holdings, Inc.

MEDP

$335.74 -3.36%
Downtrend

RadNet, Inc.

RDNT

$62.41 -1.23%
Uptrend

Sotera Health Company

SHC

$15.65 -5.04%
Uptrend

Neogen Corporation

NEOG

$15.42 -3.56%
Downtrend

Myriad Genetics, Inc.

MYGN

$26.97 -2.49%
Uptrend

Castle Biosciences, Inc.

CSTL

$29.32 -0.54%
Uptrend

Biodesix, Inc.

BDSX

$1.85 0.00%
Uptrend

ETF Exposure (18)

Vanguard Strategic Small-Cap Equity Fund Investor Shares

VSTCX

0.05%

$39.93 -1.87%
Neutral

iShares Micro-Cap ETF

IWC

0.0218%

$117.00 -1.56%
Neutral

Invesco Nasdaq Biotechnology ETF

IBBQ

0.008%

$23.54 -1.09%
Neutral

iShares Biotechnology ETF

IBB

0.00798%

$142.75 -1.41%
Neutral

ProShares Ultra Nasdaq Biotechnology

BIB

0.002425484380792945%

$62.27 -2.67%
Neutral

Schwab U.S. Small-Cap ETF

SCHA

0.0017794971%

$48.38 -1.79%
Neutral

Fidelity Nasdaq Composite Index ETF

ONEQ

0%

$65.88 -2.65%
Neutral

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$48.18 -0.99%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$48.17 -0.99%
Neutral

Vanguard Balanced Index Fund

VBINX

0%

$48.17 -0.99%
Neutral

Vanguard Health Care Index Fund

VHT

0%

$281.39 -0.51%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$129.08 -1.69%
Neutral

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$92.34 -1.71%
Neutral

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$92.32 -1.71%
Neutral

Vanguard Total Stock Market Index Fund

VITSX

0%

$129.67 -1.71%
Neutral

Vanguard Total Stock Market Index Fund

VTI

0%

$266.44 -1.66%
Neutral

Vanguard Total Stock Market Index Fund

VTSAX

0%

$129.65 -1.71%
Neutral

Vanguard Extended Market Index Fund

VXF

0%

$170.15 -1.70%
Neutral